EarningsQ4 2024 Earnings Report

Wuxi Biologics (Cayman) (2269N) Q4 2024 Earnings Report

0 Followers

MX:2269N Q4 2024 EPS Results

Actual EPS$0.60

Consensus EPS$1.18

Beat/MissMissed by -$0.58

One Year Ago EPS$0.70

Actual Revenue$25.12B

Expected Revenue$25.90B

Beat/MissMissed by -$787.70M

YoY Revenue Growth+18.74%

QuarterQ4 2024

Date03/25/2025

TimeBefore Open

Conference CallTuesday, March 25, 2025

MX:2269N Upcoming Earnings

Wuxi Biologics (Cayman)'s next earnings date is estimated for March 23, 2027, based on past reporting schedules.

MX:2269N Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 23, 2027	2026 (Q4)	1.94 / -	1.559	―
Aug 25, 2026	2026 (Q2)	1.21 / 1.55	1.474	5.45% (+0.08)
Mar 24, 2026	2025 (Q4)	1.69 / 1.56	0.516	202.22% (+1.04)
Aug 19, 2025	2025 (Q2)	1.21 / 1.47	0.938	57.14% (+0.54)
Mar 25, 2025	2024 (Q4)	1.18 / 0.60	0.699	-13.79% (-0.10)
Aug 21, 2024	2024 (Q2)	1.10 / 0.94	1.739	-46.07% (-0.80)
Mar 26, 2024	2023 (Q4)	0.72 / 0.70	1.176	-40.55% (-0.48)
Aug 23, 2023	2023 (Q2)	1.10 / 1.74	1.551	12.09% (+0.19)
Mar 22, 2023	2022 (Q4)	1.07 / 1.18	0.991	18.65% (+0.18)
Aug 17, 2022	2022 (Q2)	10.59 / 1.55	1.125	37.86% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed